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The two-phase sampling design is a cost-efficient way of collect-
ing expensive covariate information on a judiciously selected sub-
sample. It is natural to apply such a strategy for collecting genetic
data in a subsample enriched for exposure to environmental factors
for gene-environment interaction (G x E) analysis. In this paper, we
consider two-phase studies of G x E interaction where phase I data
are available on exposure, covariates and disease status. Stratified
sampling is done to prioritize individuals for genotyping at phase II
conditional on disease and exposure. We consider a Bayesian anal-
ysis based on the joint retrospective likelihood of phases I and II
data. We address several important statistical issues: (i) we consider
a model with multiple genes, environmental factors and their pairwise
interactions. We employ a Bayesian variable selection algorithm to re-
duce the dimensionality of this potentially high-dimensional model;
(ii) we use the assumption of gene–gene and gene-environment in-
dependence to trade off between bias and efficiency for estimating
the interaction parameters through use of hierarchical priors reflect-
ing this assumption; (iii) we posit a flexible model for the joint
distribution of the phase I categorical variables using the nonpara-
metric Bayes construction of Dunson and Xing [J. Amer. Statist.
Assoc. 104 (2009) 1042–1051]. We carry out a small-scale simula-
tion study to compare the proposed Bayesian method with weighted
likelihood and pseudo-likelihood methods that are standard choices
for analyzing two-phase data. The motivating example originates
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from an ongoing case-control study of colorectal cancer, where the
goal is to explore the interaction between the use of statins (a drug
used for lowering lipid levels) and 294 genetic markers in the lipid
metabolism/cholesterol synthesis pathway. The subsample of cases
and controls on which these genetic markers were measured is en-
riched in terms of statin users. The example and simulation results
illustrate that the proposed Bayesian approach has a number of ad-
vantages for characterizing joint effects of genotype and exposure over
existing alternatives and makes efficient use of all available data in
both phases.
1. Introduction. Case-control studies are popular analytical tools, par-
ticularly in cancer epidemiology, for assessing gene-disease association where
the allele/genotype frequencies at a bi-allelic single nucleotide polymorphism
(SNP) locus are compared between cases and controls. Recent genomewide
case-control association studies (GWAS) have been remarkably successful in
identifying susceptibility loci for many cancers [Yeager et al. (2007), Hunter
et al. (2007), Amundadottir et al. (2009)]. A large fraction of variability in
the different cancer traits still remain unexplained, with the identified SNPs
contributing modestly to prediction of disease risk [Wacholder et al. (2010),
Park et al. (2010)]. In search of the missing heritability, it is thus natural to
study the genetic architecture of a cancer phenotype in conjunction with the
known environmental risk factors (environmental toxins, dietary exposures,
physical activity levels, medication use and other behavioral risk factors).
In the post-GWAS era, more efficient statistical approaches to characterize
such complex gene-environment (G x E) interactions, in terms of both de-
sign and analytic tools, have become a pressing need in cancer epidemiology
research.
Variants of the case-control sampling design have been often employed
in epidemiologic studies. Two-phase stratified sampling [Neyman (1938)] is
an efficient alternative to the traditional cohort and case-control designs
[Cochran (1963)] from cost and resource-saving perspectives. A typical ap-
plication of two-phase sampling is for collecting expensive covariate infor-
mation, for example, novel biomarkers or genotype data on a prioritized
subsample of the initial study base. In particular, we will consider the fol-
lowing setup: the binary disease outcome or case-control status D, some
relatively inexpensive covariates (S) and environmental data (E) are col-
lected at phase I (P1). At phase II (P2), genotype data (G) is collected on a
subset selected from the phase I sample. To select this phase II subsample,
stratified sampling with strata defined by phase I data (D, E and possibly S)
is implemented.
There is a large amount of literature on two-phase designs, using different
likelihood based approaches [Horvitz and Thompson (1952), Flanders and
Greenland (1991), Breslow and Cain (1988)] or estimating score approaches
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[Reilly and Pepe (1995), Chatterjee, Chen and Breslow (2003), Robins, Rot-
nitzky and Zhao (1994)]. Maximum likelihood inference for such problems
was considered in the pioneering work of Scott and Wild (1997) and Bres-
low and Holubkov (1997a, 1997b). Lawless, Kalbfleisch and Wild (1999) and
Breslow and Chatterjee (1999) compare and contrast several approaches for
analyzing two-phase data. It has been noted that adding more phases can
lead to further efficiency gains, consequently, the two-phase design has been
generalized to multi-phase designs [Whittemore and Halpern (1998), Lee,
Scott and Wild (2010)]. Haneuse and Chen (2011) propose an intermedi-
ate phase between phases I and II to reduce participation bias caused by
differential participation.
The potential for such sampling designs for G x E studies has been in-
dicated in Durt (2010). Many GWAS adopt this sampling at the design
phase, but little attention is paid at the analysis stage to address the sam-
pling design, thus potentially leading to biased estimates. To the best of our
knowledge, literature on two-phase studies of G x E interaction is very lim-
ited. Chatterjee and Chen (2007) proposed maximum likelihood inference
using a novel regression model for G x E interaction studies where second
stage sampling was carried out based on disease outcome and family history.
Asymptotic theories were established under the assumption of independence
of the genetic and environmental factors in the population.
Multiple papers [Piegorsch, Weinberg and Taylor (1994), Umbach and
Weinberg (1997), Chatterjee and Carroll (2005)] attest the phenomenon of
gaining efficiency in studies of G x E by exploiting independence between the
genetic and environmental factors under case-control sampling. Under such
constraints, it is beneficial to use the retrospective likelihood for estimating
interaction parameters instead of standard prospective logistic regression.
However, with departures from these constraints, biases in estimating the
interaction parameter can occur under retrospective methods. Several re-
searchers have addressed this issue and proposed more robust strategies for
testing G x E interaction [Mukherjee et al. (2008, 2010), Mukherjee and
Chatterjee (2008), Vansteelandt, VanderWeele and Robins (2008), Li and
Conti (2009), Murcray, Lewinger and Gauderman (2009)]. There is no stan-
dard multivariate tool for handling multiple genetic markers simultaneously
for G x G and G x E studies that data-adaptively exploits gene–gene and
gene-environment independence for gaining efficiency in estimating multiple
SNP x E interaction parameters in a potentially high-dimensional model.
Bayesian literature on two-phase studies, even beyond the context of G
x E studies, is also very limited. Haneuse and Wakefield (2007) presented
the first hierarchical Bayesian work that closely relates to such data struc-
ture. The Bayesian framework presented in this paper appears to be a nat-
ural route to explore for multiple reasons. First, Bayesian estimation can
lead to efficient computational algorithms, as the two-phase likelihood is
4 AHN, MUKHERJEE, GRUBER AND GHOSH
naturally a missing data likelihood. Second, for G x E studies, Bayesian
methods provide data-adaptive shrinkage to leverage the constraints of gene-
environment independence by imposing informative priors around this as-
sumption. Third, we incorporate Bayesian variable selection features which
help us to handle a potentially high-dimensional disease risk model with
main effects and interactions of multiple genes and environmental factors
simultaneously. Fourth, we use the clever nonparametric Bayesian construc-
tion of Dunson and Xing (2009) as a substitute for profile likelihood in the
frequentist setting to construct the retrospective likelihood under two-phase
sampling. The current paper thus contributes to analysis of G x E studies
with multiple markers/environmental exposures under an outcome-exposure
stratified two-phase sampling design by offering a new Bayesian treatment
of the problem. Our data analysis and simulation studies illustrate that for
characterizing subgroup effects of the environmental exposure across geno-
type categories, our method provides gain in efficiency compared to other
alternatives. Moreover, there are no comparable alternatives that can offer
the flexibility of our method in terms of multi-marker models and efficient
G x E analysis under the two-phase design.
The paper is largely motivated by an example that originates from a
population based case-control study of colorectal cancer (CRC) in Israel,
namely, the Molecular Epidemiology of Colorectal Cancer (MECC) study.
Statins (our environmental factor E) are a class of lipid-lowering drugs used
by more than 25 million individuals worldwide for reducing cardiovascular
disease risk. The MECC study was the first to establish a chemoprotective
association of statins with risk of CRC [Poynter et al. (2005)]. Follow-up
individual studies and a meta analysis of 18 studies have confirmed this as-
sociation [Hachem et al. (2009)]. The benefit of statins for reducing CRC risk
has been shown to vary with genetic variations in the HMGCR (3-Hydroxy-
3-methylglutaryl coenzyme A reductase) gene, a gene involved in cholesterol
synthesis [Lipkin et al. (2010)]. To understand the mechanism of effect mod-
ification further, investigators measured 294 SNPs in 40 genes, including
HMGCR (our set of genetic factors G), selected in the cholesterol synthe-
sis/lipid metabolism pathway. The subsample selected for genotyping from
the study population of all cases and controls was chosen by stratified sam-
pling conditional on statin use (E) and case-control status (D) where statin
users were purposefully oversampled. This sampling strategy was adopted
due to limited budgetary resources and DNA samples. Complete statin use
(E) data and other basic demographic covariates (S) were available on the
entire study base (phase I or P1), and genetic data on these 294 SNPs were
only available for the phase II subsample (P2).
In addition, in the MECC study, due to experimental and laboratory
logistics, genotype data were missing on a subset of individuals selected in
P2 on a group of genes (G1, say) and on a different subset of individuals on
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Fig. 1. Data structure under two-phase sampling with partial missingness in phase II
genetic covariates from the Molecular Epidemiology of Colorectal Cancer study.
another group of genes (G2, say). This led to a nonmonotone missing data
structure with some individuals in P2 having observations on both (G1,G2)
[subset denoted by P2(G1,G2)] and some only on G1 [subset denoted by
P2(G1)] and some only on G2 [subset denoted by P2(G2)]. Figure 1 is a flow
diagram of the sampling scheme and missingness pattern in the data.
The rest of the paper is organized as follows. In Section 2 we present
the model ingredients: the likelihood, priors and posteriors. In Section 3
we discuss the analysis of statin x gene interaction in the MECC study. In
Section 4 we conduct a simulation study to compare the various maximum
likelihood and score based approaches with the Bayesian approach. Section 5
concludes with a discussion.
2. Proposed methods.
2.1. The likelihood. We refer to Figure 1 for understanding the data
structure and construction of our likelihood. Let u and D denote the subject
indicator and disease status, respectively. Here, E is environmental exposure
and S are basic demographic covariates as described before. LetW = (E,S).
There are N individuals in phase I andM individuals in phase II. To simplify
notation, we write the retrospective likelihood corresponding to a two-gene
model (G1, G2), with the understanding that the methods/notation can be
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directly extended to gene-sets (G1,G2) where each contain multiple SNPs.
The two-phase likelihood has the following form to capture the sampling
phases and the missingness patterns in G (Figure 1):
LTP =
∏
u∈P1\P2
P(Wu|Du)×
∏
u∈P2(G1)
P(G1u,Wu|Du)
×
∏
u∈P2(G2)
P(G2u,Wu|Du)×
∏
u∈P2(G1,G2)
P(G1u,G2u,Wu|Du).
Each term in LTP can be factorized by using P(G1,G2,W |D) = {P(D|G1,
G2,W ) P(G1,G2|W )P(W )}/P(D). This retrospective likelihood is then mar-
ginalized over the missing data in each term. We assume missing completely
at random [Little and Rubin (2002)] for the genotype data collected at
phase II. The likelihood is then expressed as
LTP =
∏
u∈P1\P2
∑
g1,g2
P(Du|g1, g2,Wu)P(g1, g2|Wu)P(Wu)/P(Du)
×
∏
u∈P2(G1)
∑
g2
P(Du|G1u, g2,Wu)P(G1u, g2|Wu)P(Wu)/P(Du)(2.1)
×
∏
u∈P2(G2)
∑
g1
P(Du|g1,G2u,Wu)P(g1,G2u|Wu)P(Wu)/P(Du)
×
∏
u∈P2(G1,G2)
P(Du|G1u,G2u,Wu)P(G1u,G2u|Wu)P(Wu)/P(Du),
where P(Du) =
∑
g1,g2
∫
w
P(Du|g1, g2,w)P(g1, g2|w)P(dw) with the integral
replaced by the sum when components of W are discrete. Corresponding to
this likelihood, there are three model ingredients:
1. A disease risk model. We assume P(D = 1|G1 = g1,G2 = g2,W =
w;β) =H[{β0 +m(g1, g2,w;β)}], where H is the logistic function H(u) =
{1 + exp(−u)}−1. Typical choice of m involves, say, for two genes G1 and
G2, m(g1, g2,w;β) = βG1g1 + βG2g2 + βEe+ β
⊤
S s+ βG1G2g1g2 + βG1Eg1e+
βG2Eg2e, noting that w = (e, s).
2.A model for (G1,G2|W = (E,S)). For genotype data at a bi-allelic lo-
cus, Gj can take three possible values (“g0 = aa,” “g1 =Aa” and “g2 =AA”).
We assume, P(G1 = gj ,G2 = g
′
j|W = w;λ) = qjj′(w;λ), j, j
′ = 0,1,2. This
specification will require a joint model for multivariate categorical data
(trinary for SNP data at a bi-allelic locus). Under gene–gene and gene-
environment independence, the model can in general be factorized condi-
tional on covariates S, for j, j′ = 0,1,2,
P(G1 = gj ,G2 = g
′
j |E = e,S= s;λ) = P(G1 = gj |S= s,λ1)P(G2 = g
′
j |S= s,λ2)︸ ︷︷ ︸
under G-G and G-E independence
.
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Instead of the above fully nonparametric model, we explore a paramet-
ric model for the joint distribution P(G1,G2|W ). We consider a class of
log-linear models with linear by linear structure [Agresti (2002)] for parsi-
monious modeling of the (G1,G2|W ) associations,
log{µ(G1 = gj,G2 = g
′
j |E = e,S= s;λ)}
= λ0 + λG1gj + λG2g
′
j + λEe+λ
⊤
S s(2.2)
+ λG1G2gjgj′ + λG1Egje+ λG2Egj′e+ λ
⊤
G1S
gjs+λ
⊤
G2S
gj′s,
where gj are chosen ordinal scores, typically 0, 1, 2 [Agresti (2002)]. This
is the common allelic dosage coding under a log-additive genetic suscepti-
bility model. Our method could easily be extended to a co-dominant cod-
ing of the genetic factor using two dummy variables. Since log-additivity
is often assumed for screening interactions, and for simplicity of presen-
tation in terms of one parameter estimate as opposed to two, we proceed
with this additive coding. Additionally, even if the true genetic suscepti-
bility model is co-dominant with the disease-causing allele, for a tagging
marker which is correlated to this causal allele, one would not a’priori
know the direction of association of the marker allele and causal allele.
Pfeiffer and Gail (2003) show that the additive scores are more robust to
choice of marker allele and varying correlation scenarios. In case of high-
dimensional G, we can further reduce the dimensionality of the problem
by assuming common association parameters λGE and λGS between simi-
lar functional groups of SNPs. As discussed in Agresti (2002), this Poisson
log-linear model has a corresponding multinomial representation. Thus, the
probability of PG1,G2(gj , g
′
j |λ) = P (G1 = gj ,G2 = g
′
j |E = e,S = s) can be
written in terms of the multinomial probabilities,
PG1,G2(gj , g
′
j |λ)
= exp(λG1gj + λG2g
′
j + λG1G2gjgj′
+ λG1Egje+ λG2Eg
′
je+ λ
⊤
G1S
gjs+λ
⊤
G2S
g′js)
×
(
2∑
l=0
2∑
l′=0
exp(λG1gl + λG2g
′
l + λG1G2glg
′
l′
+ λG1Egle+ λG2Eg
′
l′e+λ
⊤
G1S
gls+λ
⊤
G2S
g′l′s)
)−1
.
Note that gene–gene and gene-environment independence in the above
model (2.2) will imply λG1E ≡ λG2E ≡ λG1G2 ≡ 0.
3. A model for W = (E,S). A nonparametric and flexible model for the
distribution ofW is desired. Recall thatW can be a mixed set of quantitative
and categorical variables. For the MECC example W is a set of categorical
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covariates, which will be our primary focus in this paper. The approach
for modeling the joint distribution of a set of categorical variables that we
follow for W can also be applied to the the joint distribution of the trinary
genotype variables G1 andG2 in (2.2) as well. However, reflecting prior faith
on the gene–gene and gene-environment independence assumptions through
direct priors on parameters λG1E, λG2E, λG1G2 in the log-linear model is more
straightforward for a practitioner (2.2). This is the primary reason for using
(2.2) for the second component P (G1,G2|W = (E,S)).
Let Wu = (Eu,Su) denote the W data corresponding to subject u, u=
1, . . . ,N . Here Wu is p× 1 vector of p categorical variables, that is, Wu =
(wu1, . . . ,wup) for a subject u. Assume that the jth component of W can
have dj values j = 1, . . . , p. In order to parsimoniously model this (d1× d2×
· · · × dp) joint distribution, DX first note that the joint distribution of two
categorical variables can always be expressed as a finite mixture of product-
multinomial distributions. Extending this idea, DX introduce a latent class
index variable zu ∈ {1, . . . , k}, such that wur,wut, r, t ∈ {1, . . . , p}, r 6= t, are
conditionally independent given zu. Then the joint distribution for wu has
this finite mixture representation,
PW (wu1 = c1, . . . ,wup = cp)
=
k∑
h=1
P (wu1 = c1, . . . ,wup = cp|zu = h)P (zu = h)(2.3)
=
k∑
h=1
P (zu = h)
p∏
j=1
P (wuj = cj |zu = h).
For notational convenience, we rewrite (2.3) as
PW (wu1 = c1, . . . ,wup = cp) = pic1···cp =
k∑
h=1
νh
p∏
j=1
ψ
(j)
hcj
,
(2.4)
d1∑
c1=1
· · ·
dp∑
cp=1
pic1···cp = 1,
where ν = (ν1, . . . , νk)
⊤ is a probability vector with νh = P (zu = h) and
ψ
(j)
hcj
= P (wuj = cj |zu = h) is a dj × 1 probability vector, that is, the condi-
tional probability of wuj = cj , given that subject u is in latent class h for
j = 1, . . . , p. We will discuss the choice of k through a Dirichlet process prior
structure on this latent class probability model in the next section.
Remark 1. While Chatterjee and Chen (2007) and Chatterjee and Car-
roll (2005) use profile likelihood for handling the distribution of W nonpara-
metrically, it has been a challenging task in the Bayesian framework to posit
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a flexible model for W= (E,S) which could be a mixture of categorical and
continuous covariates. In this mixed case, Mu¨ller et al. (1999) model the
joint distribution of the continuous covariates through a Dirichlet process
mixture of normals. Then, conditional on the continuous covariates, the cate-
gorical variables have a joint multivariate probit distribution. A recent paper
by Bhattacharya and Dunson (2012) extends the above DX construction for
categorical data to handle joint distribution modeling of more complex data,
including continuous and discrete data. They extend the conditional inde-
pendence idea and replace the product-multinomial structure in (2.4) by a
product of various kernels, such as Gaussian, Poisson and more complex uni-
variate or multivariate distributional kernels. The MECC example does not
require going beyond the original DX construction, but with continuous E,
this is what we would adopt.
Remark 2. If the phase I sample is a cohort study, with disease end-
point D, then the corresponding likelihood is proportional to
Lcohort,TP ∝
∏
u∈P1\P2
∑
g1,g2
P(Du|g1, g2,Wu)P(g1, g2|Wu)
×
∏
u∈P2(G1)
∑
g2
P(Du|G1u, g2,Wu)P(G1u, g2|Wu)
(2.5)
×
∏
u∈P2(G2)
∑
g1
P(Du|g1,G2u,Wu)P(g1,G2u|Wu)
×
∏
u∈P2(G1,G2)
P(Du|G1u,G2u,Wu)P(G1u,G2u|Wu).
Similarly, if environmental data E is collected in phase II as well, the first
term representing the phase I cohort likelihood can also involve an integral
over the missing E data with respect to a probability distribution dF (E),
exactly as in equation (3) of Chatterjee and Chen (2007). A surrogate mea-
sure of E, namely, E∗, may be available in phase I and a measurement error
model relating E and E∗ can also be used to construct a joint likelihood of
phases I and II data.
2.2. Priors. As mentioned before, for this complex retrospective likeli-
hood formulation, we have three sets of parameters from the above three in-
gredients of the likelihood. For β in the disease risk model, we use a spike and
slab type mixture prior to handle variable selection in a high-dimensional dis-
ease risk model with multiple markers. For λ in the multivariate gene model,
the Bayesian hierarchical approach provides a flexible way to allow for un-
certainty around the assumption of gene–gene and gene-environment inde-
pendence, through prior on λG1G2 , λG1E and λG2E . When sparsity occurs in
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a certain configuration of (G1,G2,W) or dimension of (G1,G2,W) grows,
the frequentist profile likelihood estimation may become unstable and the
log-linear model with shared parameters across gene-sets and the DX latent
mixture construction aid with such situations. We follow the same sequence
as in the previous section to describe the prior structure on the parameters.
1. In the presence of multiple genes in G1 and G2, the logistic disease
risk model can potentially have many pairwise and higher order interaction
terms. We implement a scalable variable selection framework via spike and
slab type priors [Mitchell and Beauchamp (1988), George and Mcculloch
(1993)] on the parameters β in the disease risk model P (D|G1,G2,W ;β).
We impose mixture prior distributions on each component of β, say, (β0, βG1 ,
βG2 , βE , βS , βG1G2 , βG1E , βG2E) for a two-gene model. In general, we denote
this vector by βnβ×1 = {βr, r= 1, . . . , nβ}. Given a latent variable p0 repre-
senting the mixture weight on the “not informative” regression coefficients,
we describe the hierarchical prior structure as follows:
βr|fr, τr
ind
∼ N(0, frτ
2
r ), r= 1, . . . , nβ,
fr|v0, p0
i.i.d.
∼ p0δv0(·) + (1− p0)δ1(·),
τ−2r |a1, a2
i.i.d.
∼ Gamma(a1, a2),
p0
i.i.d.
∼ Beta(a, b).
As discussed in Ishwaran and Rao (2003), v0 in the above specification is
assumed to be a small positive value near 0. Note that fr can assume two
values v0 or 1. At each iteration of posterior sampling, fr takes value 1 if
sampled βr is significantly away from zero, implying that the rth covariate is
potentially informative. Note that a key feature of this prior specification is
that the marginal prior variance of βr is calibrated as var(βr) = frτ
2
r and has
a bimodal distribution. Large var(βr) can occur when fr = 1 and τ
2
r is large,
inducing large values of βr, identifying potentially informative covariates.
Small values of var(βr) occur when fr assumes value v0, leading to values of
βr that are near zero, suggesting that βr is potentially uninformative. The
value of p0 controls how likely it is for fr to be v0 or 1, thus controlling
how many βr are nonzero or the complexity of the model. The Gamma
parameters (a, b) control the degree of parsimony through the prior on p0.
We set (a, b) = (1,1), that is, a uniform prior on p0, for the analysis we
present in the main text. Note that (a1, a2) determines the prior on τ
2
r and
thus the variance of βr. We fix (a1, a2) at (5,50) to allow the possibility of
large prior variances on β. The values used for the hyperparameters in the
hierarchy are exactly as recommended in Ishwaran and Rao (2003).
2. In the joint log-linear model (2.2), we typically assume vague normal
priors with large variance on the parameters (λG1 , λG2 , λG1S , λG2S). In our
data example, we have used a N(0,104) prior. On the other hand, for the
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G-E pairwise association parameters (λG1G2 , λG1E , λG2E), we reflect a priori
information on G-G or G-E independence via a normal prior centered at zero
but with two different choices for the prior variance. In the first set of priors
we reflect the belief that with 95% probability the association parameter
lies between log(0.8) and log(1.2). This leads to an approximate SD = 0.1
under a normal distribution and, thus, we assume an informative prior of
N(0,10−2). In the second choice, following the empirical Bayes estimation
of Mukherjee and Chatterjee (2008), we compute association parameters for
G1-G2, G1-E, and G2-E in the control subjects in the data, say, θˆ, and use
a data-driven prior N(0, θˆ2) on λG1G2 , λG1E and λG2E .
3. The mixture representation in (2.4) requires determining the number
of latent classes k. Following DX, instead of selecting a fixed k, a Bayesian
nonparametric approach is carried out through the Dirichlet process prior
specification on ν:
pi =
∞∑
h=1
νhψh, ψh =ψ
(1)
h ⊗ · · · ⊗ψ
(p)
h , h= 1, . . . ,∞,
ψ
(j)
h ∼Dirichlet(aj1, . . . , ajdj) independently for j = 1, . . . , p,
νh =
∞∑
h=1
Vh
∏
l<h
(1− Vl), Vh ∼Beta(1, α),
α∼Gamma(aα, bα),
where ⊗ is the outer product. The parameter α is a hyper-parameter that
controls the rate of decrease from the stick-breaking process [Sethuraman
(1994)]. For example, in the case of small values of α, νh decreases toward
zero quickly with increasing h, thus putting most of the weight on the first
few components, leading to a sparse representation. The hyperprior on α
allows one to data-adaptively determine the degree of sparseness or the
number of components needed. As discussed in Dunson and Xing (2009), we
set (aα, bα) = (1/4,1/4) for a vague prior which implies the probability of
independence across components of w in the product multinomial model to
be 0.5. We set uniform priors for each category probability ψ with aj1 = · · ·=
ajdj = 1, for j = 1, . . . , p and let the data dominate over priors. To minimize
large numbers of mixture components instead of using infinite mixtures, we
truncate the maximum of the number of mixture components k at 30 in the
real data example [Ahn et al. (2013)]. We study sensitivity with respect to
this truncation threshold in Table 1.
2.3. Posterior sampling. In the full likelihood (2.1), we would like to
point out that the three components are linked with each other through
the sum over each component in the expression for P (D) in the denomina-
tor. We denote the two-phase likelihood in (2.1) by LTP which involves the
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parameters (β,λ,ψ,V, α). The full conditionals are not reducible to a sim-
pler closed form and are best represented by the following proportionality
relations:
βr|· ∝ L
TP × exp
(
−
β2r
2frτ2r
)
, r= 1, . . . , nβ,
τ−2r |· ∝Gamma
(
a1 + 0.5, a2 +
β2r
2fr
)
,
fr|· ∝ {I(fr = v0)p0 + I(fr = 1)(1− p0)} × exp
(
−
1
2frτ2r
β2r
)
× f−0.5r ,
p0|· ∝ Beta
(
a+
nβ∑
r=1
I(fr = v0), b+
nβ∑
r=1
I(fr = 1)
)
,
λl|· ∝ L
TP × exp
(
−
λ2l
2σ2
)
, l= 1, . . . , nλ,
where nβ and nλ again represent the number of parameters in (β,λ), re-
spectively.
Posterior sampling corresponding to P (W): Let us recapitulate the model
structure for W which is essentially a Dirichlet process mixture of discrete
Dirichlet kernels. For u= 1, . . . ,N and j = 1, . . . , p,
wuj ∼Multinomial({1, . . . , dj}, ψ
j
zu,1
, . . . , ψjzu,dj ),
zu ∼ Vh
∏
l<h
(1− Vl)δh, Vh ∼Beta(1, α), α∼Gamma(aα, bα).
DX present an efficient data-augmented Gibbs sampling algorithm by aug-
menting the likelihood with latent constructs following Walker (2007). The
details of the updating steps are described in the supplemental article [Ahn
et al. (2013)].
Note that while the entire likelihood in DX is constituted of W data only,
in our problem, P (W) is embedded as a component in the joint retrospec-
tive likelihood LTP in (2.1). Thus, for updating the parameters involved in
P(W), say, θ(={ψ,V, α}), we use the Metropolis Hastings algorithm. Only
the terms
∏
uP(Wu)/P(Du) from the full likelihood (2.1) involve θ, where
P(Du) =
∑
g1,g2
∑
w
P(Du|g1, g2,w) P(g1, g2|w)P(w). We draw θ following
the DX algorithm and for the proposal density of θ we consider the implied
full conditional q(θnew|W) as determined by this algorithm. Then given
λ,β, we repeat the following updates of θ:
• At iteration l, sample a vector θnew from q(θnew|W) as described in the
Dunson and Xing (2009) algorithm.
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• Compute the acceptance ratio
r(θnew,θl) = min
[
1,
∏
uP(Du|θl,λ,β)∏
uP(Du|θ
new,λ,β)
]
.
In calculating the acceptance ratio, we note that the numerator and de-
nominator
∏
u{P(Wu|θ
new)}p(θnew) q(θl|W)/
∏
u{P(Wu|θl)}p(θl)q(θ
new|
W) are canceled out where p(θ) is a prior for θ.
• If r(θnew,θl) < U where U ∼ unif(0,1), we set θl+1 = θ
new. Otherwise,
the candidate vector θnew is rejected and θl+1 = θl.
• Repeat the steps until the posterior chains converge.
Given the full conditionals, we implement the Gibbs sampler [Geman and
Geman (1984)] with Metropolis Hastings updates to sample from respective
full conditional distributions. For each parameter, we iterate 50,000 times
and discard the first 40,000 iterations as “burn-in.” We check convergence of
the chains using trace plots and the numerical diagnostic statistic “potential
scale reduction factor” [David (1992)] using the R package CODA [Plummer
et al. (2009)]. Auto and cross-correlation checks are performed and a thin-
ning of every tenth observation is carried out. Remaining posterior samples
are used to construct estimated posterior summaries needed for Bayesian
inference.
3. The Molecular Epidemiology of Colorectal Cancer study. In this sec-
tion we describe the motivating example from the MECC study in detail and
present analysis results. We use data on 1746 cases and 1853 controls with
completely observed response to the question whether statins were used for
more than 5 years. The binary variable “statin use of at least 5 years” (E)
is the environmental factor of interest with 91% “NO” and 9% “YES.”
We adjust for completely observed confounders and precision variables
(S): age (S1), gender (S2), ethnicity (S3), physical activity (S4), family
history of CRC (S5), vegetable consumption (S6), NSAID usage within 3
year (S7) and Aspirin usage within 3 year (S8). Age and ethnicity variables
were dichotomized as Age ≥ or < 50 (94% and 6%, resp.), and “Ashke-
nazi” and “Non-Ashkenazi” (68% and 32%, resp.). Gender (S3) was coded
as 1 (50%) for male and 0 (50%) for female. The remaining binary factors
(S4, S5, S6, S7, S8) are classified to 1 or “YES” with the proportions of (0.36,
0.09, 0.31, 0.02, 0.20), respectively.
For genotyping at phase II, stratified-sampling based on the disease sta-
tus (D) and statin use (E) was carried out. All case-control subjects with
statin use (“YES”) were included at the phase II sample. We have 1200
cases and 1200 controls at phase II with data available on 294 trinary SNPs
G = (G1, . . . ,G294). Genotype data are not completely observed even at
phase II due to technical genotyping failures for a limited number of SNPs.
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Among 2400 case-control subjects at phase II, 56 subjects and 20 had par-
tial genotype information on two subsets of SNPs. We did not have a dense
set of markers typed across the genome to successfully impute these missing
genotypes, thus we consider a marginalized likelihood as in (2.1).
Among 294 SNPs, we first illustrate our methods with two SNPs on two
genes, RS1800775 on CETP (G1) and RS1056836 on CYP1B1 (G2), where
both SNPs exhibit significant interactions with statin use in an initial single
marker interaction analysis. We compare our methods for this simple two
SNP model to some of the alternative methods that can only handle single
marker interaction analysis. The raw frequencies of the cross-classification
of case-control status (D), statins (E), genotypes G1 and G2 are shown in
online supplementary Table 1 [Ahn et al. (2013)]. Simple logistic regression
analysis was carried out to examine G1-E and G2-E association among con-
trol subjects and yielded odds ratios of 1.11 and 1.01 and corresponding
p-values of 0.30 and 0.91, respectively. Based on a chi-squared test for inde-
pendence, G1-G2 reveals no association (p-value of 0.90) These tests suggest
that the data support G1-E, G2-E and G1-G2 independence assumption.
We report the results of the multivariate analysis in Table 1. Along
with the two-phase full Bayes approach (TPFB), we consider five alter-
native methods. Unfortunately, none of these competing methods use the
data in both phases and make use of the independence constraints. The
first three use phase II data only (i) unconstrained maximum likelihood
(UML), a retrospective analysis that does not specify any constraints on
P (G1,G2|E,S), (ii) constrained maximum likelihood (CML), that imposes
the Hardy–Weinberg equilibrium as well as G1-E/G1-G2 independence, (iii)
empirical-Bayes (EB), using data-adaptive “shrinkage estimation” between
the constrained and unconstrained ML estimates. Since methods (ii) and
(iii) are developed for single marker analysis, G2-E independence cannot be
enforced in existing software [we used the “CGEN” package by Bhattachar-
jee, Chatterjee and Wheeler (2011)]. These three methods completely ignore
biased sampling at phase II and may thus lead to biased estimation of the
main effect of E, particularly if the exposure sampling rates were the differ-
ential among cases and controls. The next two approaches use information
from both phases under a prospective likelihood framework: (iv) a Horvitz–
Thompson estimator, typically known as a weighted likelihood (WL) ap-
proach [Manski and Lerman (1977), Breslow and Chatterjee (1999)]. This
approach uses sampling fractions nij/Nij , where nij and Nij are the number
of subjects corresponding to D = i,E = j at phases II and I, respectively.
The sampling fraction serves as weights in the likelihood to adjust for biased
sampling [we used the svyglm function in the “survey” package in R by Lum-
ley (2011)]. Finally, (v) a pseudo-likelihood (PL) approach which also ad-
justs for biased sampling probabilities in a likelihood framework [Schill et al.
(1993)]. Briefly, if we denote Pij = P (D = i|E = j) = exp(iαj)/{1+exp(αj)}
where αj is the log-odds for D = 1 when E = j, then the pseudo-likelihood
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Table 1
(a) Analysis results for the MECC study data with statins (E), G1 RS1800775 on CETP and G2 RS1056836 on CYP1B1. The model
adjusts age (S1, “>50” = 1, “≤50” = 0), gender (S2, male = 1, female = 0), ethnicity (S3, Ashkenazi = 1, Non-Ashkenazi = 0), sports
activity (S4, Yes = 1, No = 0), vegetable consumption (S5, High = 1, Low = 0), family history of CRC (S6, Yes = 1, No = 0), the use or
nonuse of NSAID within 3 years (S7, Yes = 1, No = 0), the use or nonuse of Aspirin within 3 years (S8, Yes = 1, No = 0). Under the
TPFB method the “est.” corresponds to the posterior mean, whereas PSD corresponds to posterior standard deviation. The methods
that yield the smallest PSD are in bold font in each row
TPFB TPFBemp WL PL UML CML EB
est.(PSD) est.(PSD) est.(se) est.(se) est.(se) est.(se) est.(se)
Exposure variables
G1 0.04 (0.09) 0.01 (0.09) 0.00 (0.09) 0.00 (0.09) 0.00 (0.09) 0.00 (0.08) −0.07 (0.08)
G2 −0.04 (0.10) −0.06 (0.10) −0.13 (0.10) −0.13 (0.10) −0.13 (0.10) −0.12 (0.08) −0.12 (0.08)
Statin use −1.29 (0.30) −1.32 (0.27) −1.30 (0.30) −1.30 (0.30) −1.40 (0.30) −1.54 (0.28) −1.51 (0.29)
G1 x G2 0.01 (0.07) 0.03 (0.05) 0.05 (0.08) 0.06 (0.08) 0.06 (0.08) 0.06 (0.06) 0.06 (0.06)
G1 x statin use 0.34 (0.17) 0.34 (0.15) 0.25 (0.18) 0.25 (0.18) 0.25 (0.18) 0.38 (0.15) 0.34 (0.17)
G2 x statin use 0.33 (0.16) 0.33 (0.16) 0.38 (0.18) 0.38 (0.19) 0.38 (0.20) 0.38 (0.18) 0.38 (0.19)
Gene-statin and gene–gene association parameters from P (G1,G2|E,S)
λG1G2 0.02 (0.05) 0.00 (0.05)
λG1E 0.05 (0.07) 0.08 (0.06)
λG2E 0.01 (0.07) 0.01 (0.07)
(b) Sensitivity analysis with respect to the maximum number of allowable mixture components kmax, and the prior on G-G and G-E
association parameters λ
G1 G2 Statin use G1 x G2 G1 x statin use G2 x statin use
kmax = 10 TPFB 0.05 (0.10) −0.03 (0.10) −1.29 (0.30) 0.01 (0.07) 0.36 (0.16) 0.32 (0.17)
TPFBemp 0.01 (0.09) −0.06 (0.10) −1.32 (0.29) 0.03 (0.07) 0.31 (0.15) 0.32 (0.16)
kmax = 30 TPFBnon 0.05 (0.11) −0.03 (0.11) −1.29 (0.31) 0.01 (0.07) 0.34 (0.19) 0.34 (0.21)
TPFB, TPFBemp, TPFBnon: Two-phase full Bayes [with informative prior N(0,10
−2), using empirical estimates for prior variances, with
noninformative prior N(0,104)] on G-E association parameters; UML: unconstrained maximum likelihood, CML: constrained maximum
likelihood, EB: empirical-Bayes, WL: weighted likelihood and PL: pseudo-likelihood.
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is defined as
∏
i,j P
Nij
ij
∏
i,j,k pijk. Here,
pijk =
nij exp{i(β0 −αj + sijkβ)}
n0j + n1j exp(β0 −αj + sijkβ)
,
where sijk denotes covariate values for a subject with D = i and E = j.
Note that all of these five methods use completely observed phase II data
on G1 and G2 as opposed to our proposed method that includes partially
observed data by marginalization of the likelihood in terms of G1 and G2
when needed.
As previously explained, we present our method (TPFB) corresponding to
two different priors on the G-E and G-G association parameters in model
(2.2). First, we consider informative prior N(0,10−2) that enforces fixed
prior belief around G-E and G-G independence; we denote this by TPFB.
The analysis using an alternative prior where the prior variances on λGG and
λGE are estimated based on observed association in the data is denoted by
TPFBemp. In Table 1, the variable selection scheme is excluded in the TPFB
and TPFBemp by assuming all fr = 1, r= 1, . . . , nβ, so that all covariates are
included across all methods. This is done so that the method can be fairly
compared to other alternatives which do not have the variable selection
feature.
Under all methods, note in Table 1 that the estimated coefficients corre-
sponding to statin-use suggest strong negative association with CRC status.
The estimated effect size varies depending on whether the method accounts
for biased sampling and/or gene-environment independence. In the presence
of interactions, we cannot really interpret the main effect estimates and need
to combine the model results to present estimated subgroup effects. Recall
that G1-E and G2-E independence does appear to be plausible in light of
this data. Note that while G2 x E interaction is detected by all methods, G1
x E interaction can only be detected by CML, EB, TPFB and TPFBemp,
that is, methods that use the independence assumption. The TPFB esti-
mates of terms involving E are slightly different in effect sizes with smaller
standard errors when compared to the other methods. Smaller standard er-
rors corresponding to interaction parameters are noted in all retrospective
methods that explicitly model (G1,G2,E) dependence structure.
We also carried out a sensitivity analyses with respect to the choice of
threshold to truncate the maximum value of k in the DX construction and
the prior on G-E and G-G association. As can be seen from Table 1(b), the
results are almost identical with a smaller number (kmax = 10) of compo-
nents in the mixture distribution forW . This suggests further computational
efficiency gain is possible by imposing more parsimonious constraint on k.
In another sensitivity analysis, when the prior on G-E association is non-
informative N(0,104), we notice TPFB estimates slightly drift toward the
estimates from PL and WL while losing some efficiency on the G1 x E and
G2 x E terms.
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Table 2
Odds ratio estimates (confidence interval or credible interval) for CRC corresponding to
statin users vs nonusers across genotype subgroups. Under all five methods, a model with
main effect of G1,G2,E controlling for S was fit as in Table 1. Common alleles in G1
(RS1800775 on CETP) and G2 (RS1056836 on CYP1B1) are A and C, respectively,
and minor alleles in G1 and G2 are C and G, respectively
Statins
G1 A/A A/C C/C A/A A/A
G2 C/C C/C C/C G/C G/G
TPFB 0.27 (0.15, 0.39) 0.35 (0.22, 0.44) 0.48 (0.26, 0.65) 0.38 (0.24, 0.51) 0.48 (0.30, 0.77)
TPFBemp 0.26 (0.15, 0.42) 0.36 (0.23, 0.45) 0.49 (0.31, 0.69) 0.37 (0.23, 0.50) 0.50 (0.31, 0.79)
WL 0.27 (0.15, 0.49) 0.35 (0.22, 0.55) 0.45 (0.26, 0.77) 0.40 (0.26, 0.62) 0.59 (0.34, 1.02)
PL 0.27 (0.15, 0.49) 0.35 (0.22, 0.55) 0.45 (0.26, 0.79) 0.40 (0.25, 0.63) 0.59 (0.33, 1.05)
UML 0.25 (0.14, 0.44) 0.32 (0.20, 0.50) 0.41 (0.23, 0.72) 0.36 (0.23, 0.57) 0.53 (0.29, 0.95)
CML 0.22 (0.12, 0.37) 0.33 (0.21, 0.51) 0.49 (0.29, 0.83) 0.34 (0.20, 0.48) 0.46 (0.26, 0.80)
EB 0.22 (0.13, 0.39) 0.31 (0.20, 0.49) 0.43 (0.24, 0.79) 0.32 (0.21, 0.49) 0.47 (0.27, 0.82)
TPFB, TPFBemp: Two-phase full Bayes (with empirical estimates for prior variances),
UML: unconstrained maximum likelihood, CML: constrained maximum likelihood, EB:
empirical-Bayes, WL: weighted likelihood, and PL: pseudo-likelihood.
To reflect our main interest in subgroup effects of statin across genotype
configurations, we report effects of statin across genotype subgroups of one
SNP, holding the other SNP fixed at the common genotype category for that
second SNP (coded as 0) in Table 2. It seems that statin effect is strongly
modified by G1 and G2. According to TPFBemp estimates, keeping the G2
genotype fixed at C/C, the benefit of taking statins to reduce the risk of CRC
is maximum in the A/A genotype of G1 with the posterior estimate (and
95% HPD) of the odds-ratios (corresponding to statin users versus nonusers)
being 0.26 (0.15, 0.42). The corresponding ORs in genotype category A/C
and C/C are 0.36 (0.23, 0.45) and 0.49 (0.31, 0.69), respectively. Figure 2
illustrates estimated posterior densities of the odds ratios corresponding
to statin-use across each genotype of G1 (left) or G2 (right), respectively,
while holding the other SNP fixed at the most common category. This figure
indicates that the protective effect of statin in CRC is diminishing as the
allelic dosage for the minor allele increases in both G1 and G2. Overall,
the TPFB approaches provide much narrower credible intervals compared
to PL and WL by exploiting G1-E and G2-E independence. The estimates
from methods that use phase II data only, like CML, UML and EB, are
numerically slightly different.
Variable selection: We explore how variable selection feature per-
forms in this example for the TPFB method. Previous research by Ishwaran
and Rao (2003) discussed the performance of spike and slab prior for gen-
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Fig. 2. The left figure shows the posterior densities of the odds ratio estimates of CRC
corresponding to statin users versus nonusers across three genotypes in RS1800775 on
CETP(G1), holding the genotype in RS1056836 on CYP1B1 at the most frequent category,
that is, (G2) = (C/C). Similarly, the right figure shows the posterior densities of the odds
ratio estimates corresponding to statin users versus nonusers across three genotypes in
RS1056836 of CYP1B1(G2), holding the genotype in RS1800775 of CETP fixed at the
most frequent category, that is, (G1) = (A/A).
eral variable selection. We introduce three SNPs (RS5925224, RS10174721,
RS10077453) and all possible pairwise G x G and G x E interactions to the
previous two SNP model as fit in Table 1. The dimension of the disease risk
model is now 34. None of the main effects and interactions corresponding to
these three additional SNPs were found significant in an initial single marker
analysis.
We set fr = 1 for S1 through S8 to always keep the confounders and pre-
cision variables in the model. The tuning parameters v0 are fixed at 0.0001
for this application with sensitivity analysis results presented for v0 = 0.001
in Table 3. We would like to see if the variable selection can still detect a
significant G1 x E and G2 x E interaction. Moreover, we would like to assess
if the three additional SNPs and the corresponding interactions we added
(with null effects as observed in our initial analysis) are also identified to
be not informative by this process. We tabulate the posterior distribution
of fr = 1 among f = (f1, . . . , fnβ) which indicate “in-and-out” frequencies
of the corresponding parameters. These posterior frequencies of fr = 1 can
be used to define a ranking of important predictors. An alternative is to
rank the top models (not just the predictors individually). Before imple-
menting the TPFB, we reduced the dimensionality of parameters in the
model P (G|W) where G= (G1,G2,G3,G4,G5) by assuming common λGG
and λGE association parameters across all SNPs. We use N(0,0.1
2) prior on
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Table 3
(a) The top 10 promising models in terms of estimated posterior probabilities of the
models. All S adjustment variables are retained in the model by default and variable
selection is performed only on the five genetic and environmental factors and all possible
pairwise interactions. Bayesian Information Criterion (BIC) is provided for each model.
Results in parentheses represent the sensitivity analysis carried out with v0 = 0.001
Model Posterior probability % BIC
[E][All S][G2 x E] 13.1% (12.5%) 43,992 (43,967)
[E][All S][G1 x E][G2 x E] 9.2% (6.3%) 43,993 (43,978)
[E][All S][G1 x E] 7.7% (5.1%) 43,994 (43,967)
[E][All S] 7.5% (10.6%) 43,997 (43,977)
[E][All S][G2 x E][G3 x E] 3.9% (4.6%) 44,004 (43,977)
[E][All S][G2 x E][G4 x E] 2.4% (2.2%) 44,002 (43,974)
[E][All S][G2 x E][G3 x G4] 2.1% (1.5%) 43,998 (43,971)
[E][All S][G1 x E][G3 x E] 2.1% (2.2%) 44,005 (43,974)
[E][All S][G1][G2 x E] 1.8% (0.7%) 43,996 (43,976)
[E][All S][G1 x E][G2 x E][G5 x E] 1.6% (2.0%) 44,010 (43,974)
BIC represents Bayesian Information Criterion.
(b) The estimated posterior probabilities of appearance corresponding to G and E main
effects and their interactions are shown under the identical setting as in Table 3(a). Results
in parentheses represent the sensitivity analysis carried out with v0 = 0.001
G1 G2 G3 G4 G5 E E x G1 E x G2 E x G3 E x G4 E x G5
6.7 5.0 4.3 4.1 7.6 100.0 36.8 64.0 18.4 10.1 13.9
(5.6) (6.8) (10.6) (7.3) (9.4) 100.0 (29.5) (55.4) (19.9) (9.7) (9.5)
this common parameter. In addition, we further assume a single common
parameter λGS for all G-S associations with a vague normal prior N(0,10
4).
These are assumptions that may be stringent in certain situations, but to
reduce estimation burden in the log-linear model, we do need to make these
assumptions for the TPFB methods. For SNPs on a same functional path-
way like in our example, it may not be too unrealistic to assume a shared
association parameter across SNPs.
In Table 3, we present numerical results on model and predictor ranking
as well as the Bayesian Information Criterion (BIC) corresponding to each
model. We only present the top 10 models. According to the result, the
model with main effects of E and G2 x E interactions seems to be the most
preferred model (posterior probability 13.1%) followed by the model with E
and both G1 x E and G2 x E interactions (posterior probability 9.2%). With
v0 = 0.001, the ranking of predictors is slightly different, as the main effects
of G1 through G5 are now selected more often. The bottom panel of Table 3
shows the frequency of retaining a predictor in the model according to the
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posterior distribution of f . The main effect of E appears most of the times
(100%) with large selection probabilities for G1 x E and G2 x E interactions
(36.8% and 64.0%), respectively. Overall, nonsignificant interactions/main
effects are well filtered under this variable selection scheme.
4. Simulation study. In this section we assess the performance of the
proposed method by conducting a simulation study. We mainly consider
two aspects: (i) varying gene-gene/gene-environment association structure
and (ii) when phase II sampling is the differential between cases and controls.
We compare our method with the five alternative methods mentioned before:
WL, PL, UML, CML and EB in terms of the average bias and mean squared
errors (MSE), based on 1000 simulated data sets.
We first describe the data generation procedure. We consider two genes
G1 and G2, and one environment factor E, with disease status D, all binary.
We generate data from the following log-linear model [Li and Conti (2009)]:
log(µ|D,G1,G2,E) = γ0 + γG1G1 + γG2G2 + γEE + γDD
+ λG1EG1E + λG2EG2E + λG1G2G1G2
(4.1)
+ βG1G1D+ βG2G2D+ βEED
+ βG1EG1ED+ βG2EG2ED+ βG1G2G1G2D,
where µ denotes expected cell counts corresponding to the (D,G1,G2,E)
configuration. Under this model, we are capable of fixing G1-E, G2-E and
G1-G2 association under controls by setting values of λG1E, λG2E and λG1G2 ,
respectively. These parameters are approximately equivalent to those in
model P (G1,G2|W ) (2.2) when the disease is rare. Similarly, we can set
βG1E , βG2E or βG1G2 , corresponding to the G x E or G x G interactions in the
disease risk model. The parameters (γ0, γG1 , γG2 , γE) control the marginal
frequencies of G1, G2 and E in controls. A large negative value of γD ensures
that the disease is rare.
For the model parameters in (4.1), we fixed (γ0, γG1 , γG2 , γE , γD) = (−6,
−0.5,−0.5,−2.0,−4.5) that produces approximately 2.5% of the cases, fre-
quency of G1 = 1 and G2 = 1 both at 45% while the prevalence of E = 1 is
15%. We assign (βG1E , βG2E, βG1G2) = (0, log(2), log(2)) in (4.1). For setting
parameters corresponding to G-E/G-G association, we set (λG1G2 , λG1E ,
λG2E) = (log(2),0, log(1.5)) to reflect G1-G2 and G2-E dependence, and
(0,0,0) for the independence scenario.
Now we turn our attention to the sampling design. We randomly generate
1000 cases and 1000 controls with complete (D,G1,G2,E) data. We then
carry out (D,E)-stratified sampling as follows. We select 600 cases and 600
controls in phase II. We consider two scenarios regarding this the stratified
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sampling strategy: (a) all subjects with a positive E(=1), in cases and con-
trols, are automatically included in phase II; (b) all subjects with a positive
E(=1) in cases are included in phase II, however, 600 controls for phase II
are randomly selected regardless of E status. Finally, information on G1 and
G2 from phase I subjects, that is, 400 cases and 400 controls, is treated as
missing by design. We iterate this step to generate 1000 replicate data sets
under each sampling scheme.
Tables 4 and 5 display the simulation results based on two different sam-
pling schemes (a) and (b), respectively. We follow the convention that ⊥
and ∼ represent independence and dependence between two variables, re-
spectively. Under G1⊥E,G2⊥E and G1⊥G2 the CML method yields the
smallest MSE with respect to G1 x E and G1 x G2 interaction followed by
TPFB, TPFBemp and EB, while WL, PL and UML present relatively larger
MSE. Here we need to note that the current implementation of CML and EB
can only use G1-E and G1-G2 independence, but not G2-E independence.
As phase II sampling becomes differential between cases and controls from
scenario (a) (Table 4) to (b) (Table 5), we notice the substantial increase
in the bias for estimating the main effect of E from CML, UML and EB as
expected, while WL, PL, TPFB and TPFBemp provide relatively less biased
estimates. This trend remains present in the case where G1⊥E,G2 ∼E and
G1 ∼ G2. Beyond the bias in βE from CML, UML and EB, we note that
under the departure from the independence assumption, namely, G1⊥G2,
there is a dramatic increase in the bias corresponding to the G1 x G2 inter-
action under CML and to some extent in TPFB. TPFBemp and EB are more
robust to this assumption. Both TPFB show gain in efficiency for interac-
tion estimation compared to PL and WL. Overall, our proposed methods,
especially TPFBemp, yield obvious gain in efficiency compared to PL and
WL in terms of the G x E or G x G interactions in the presence of in-
dependence. On the other hand, TPFBemp provides less biased estimates
of the E effect compared to UML, CML and EB which use only phase II
data. When the subsampling ratio is 80%, the pattern remains the same as
seen in online supplemental Table 2 [Ahn et al. (2013)]. We also provide
the sum of the MSEs across all parameters in order to capture the accuracy
of estimating subgroup effects defined by different G-E configurations. This
summary measure in the last columns of Tables 4 and 5 clearly suggests
that our methods yield more efficient characterization of the joint effect of
exposure and genetic factors.
Table 3 in the supplemental article [Ahn et al. (2013)] presents simula-
tion results under the traditional or unstratified case-control design when
a random sample of cases and controls are taken irrespective of E status.
We can note clear efficiency gains from stratified sampling when comparing
Table 4 to Table 3 in the supplemental article for estimating the interaction
parameters.
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Table 4
Simulation results under exposure enriched sampling with all E = 1 in phase I data selected in phase II for both cases and controls. We
consider two association scenarios: (1) G1⊥E, G1⊥G2 and G2⊥E association, (2) G1⊥E, G1 ∼G2 and G2 ∼E. The results are
based on 1000 replicated data sets, each with 1000 cases and 1000 controls in phase I and 600 cases and 600 controls in phase II. The
approaches listed, TPFB, TPFBemp, WL, PL, UML, CML and EB, each represent two-phase full Bayes (with empirically obtained prior
variance), weighted likelihood, pseudo-likeliohod, unconstrained maximum likelihood, constrained maximum likelihood, and
empirical-Bayes, respectively. The CML imposes G1-E and G1-G2 independence, however, no constraints on G2-E association. We set
(βE , βG1G2 , βG1E , βG2E) = (−1.5,0, log(2), log(2)) for all scenarios. The rows with the smallest two sum (MSE) are in bold
G1⊥E, G1⊥G2, G2⊥E G1⊥E, G1 ∼G2, G2 ∼E
Stratified sampling (a)† E G1 x G2 G1 x E G2 x E Sum (MSE)
∗
E G1 x G2 G1 x E G2 x E Sum (MSE)
∗
(λG1G2 , λG1E , λG2E) = (0,0,0) (λG1G2 , λG1E , λG2E) = (log(2),0, log(1.5))
TPFB Bias −0.024 −0.017 0.020 −0.017 −0.056 0.166 −0.022 0.119
(MSE) (0.093) (0.044) (0.120) (0.135) (0.392) (0.117) (0.081) (0.091) (0.122) (0.411)
TPFBemp Bias 0.007 −0.019 −0.021 −0.062 −0.033 0.043 −0.029 0.026
(MSE) (0.089) (0.025) (0.111) (0.126) (0.351) (0.113) (0.064) (0.091) (0.120) (0.388)
WL Bias −0.038 −0.025 0.043 0.009 −0.038 0.011 0.011 0.006
(MSE) (0.099) (0.058) (0.144) (0.157) (0.458) (0.105) (0.057) (0.101) (0.121) (0.384)
PL Bias −0.038 −0.026 0.043 0.009 −0.038 0.011 0.011 0.006
(MSE) (0.098) (0.056) (0.144) (0.157) (0.455) (0.105) (0.056) (0.101) (0.121) (0.383)
UML Bias −0.093 −0.026 0.043 0.009 −0.096 0.011 0.011 0.006
(MSE) (0.110) (0.056) (0.144) (0.157) (0.467) (0.116) (0.056) (0.101) (0.121) (0.394)
CML Bias −0.085 −0.020 0.026 0.003 −0.100 0.700 0.011 0.009
(MSE) (0.099) (0.025) (0.083) (0.155) (0.362) (0.112) (0.520) (0.070) (0.116) (0.818)
EB Bias −0.087 −0.025 0.036 0.004 −0.099 0.089 0.010 0.008
(MSE) (0.099) (0.036) (0.099) (0.155) (0.389) (0.112) (0.069) (0.075) (0.116) (0.392)
†All subjects with E = 1 in case and control are subsampled for phase II.
∗The combined MSEs as summed over all four parameters.
TPFB uses the informative prior N(0,10−2) on G-G and G-E associations in the model (2.2). TPFBemp uses the prior N(0, θˆ
2) on G-G
and G-E associations in the model (2.2) where θˆ2 is empirically estimated as the G-G or G-E association parameter under the controls.
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Table 5
Simulation results under exposure enriched sampling with all E = 1 in phase I data selected in phase II for cases but
a random sample of controls are selected in phase II. We consider two association scenarios: (1) G1⊥E, G1⊥G2,
and G2⊥E association, (2) G1⊥E, G1 ∼G2, and G2 ∼E. The results are based on 1000 replicated data sets, each with
1000 cases and 1000 controls in phase I and 600 cases and 600 controls in phase II. The approaches listed, TPFB,
TPFBemp, WL, PL, UML, CML, and EB, each represent two-phase full Bayes (with empirically obtained prior variance),
weighted likelihood, pseudo-likeliohod, unconstrained maximum likelihood, constrained maximum likelihood, and empirical-Bayes,
respectively. The CML imposes G1-E and G1-G2 independence, however, no constraints on the G2-E association. We set
(βE , βG1G2 , βG1E , βG2E) = (−1.5,0, log(2), log(2)) for all scenarios. The rows with the smallest two sum (MSE) are in bold
G1⊥E, G1⊥G2, G2⊥E G1⊥E, G1 ∼G2, G2 ∼E
Stratified sampling (b)† E G1 x G2 G1 x E G2 x E Sum (MSE)
∗
E G1 x G2 G1 x E G2 x E Sum (MSE)
∗
(λG1G2 , λG1E, λG2E) = (0,0,0) (λG1G2 , λG1E , λG2E) = (log(2),0, log(1.5))
TPFB Bias 0.007 0.022 −0.007 −0.022 −0.105 0.160 0.032 0.128
(MSE) (0.081) (0.040) (0.113) (0.124) (0.358) (0.125) (0.073) (0.106) (0.128) (0.432)
TPFBemp Bias 0.039 0.015 −0.054 −0.073 −0.027 0.036 0.024 0.000
(MSE) (0.086) (0.031) (0.127) (0.122) (0.366) (0.121) (0.058) (0.115) (0.135) (0.429)
WL Bias −0.012 0.016 0.021 0.024 −0.044 0.004 0.076 −0.014
(MSE) (0.098) (0.059) (0.165) (0.167) (0.489) (0.133) (0.056) (0.150) (0.147) (0.486)
PL Bias −0.012 0.015 0.020 0.025 −0.046 0.002 0.077 −0.013
(MSE) (0.097) (0.059) (0.164) (0.166) (0.486) (0.132) (0.055) (0.149) (0.146) (0.482)
UML Bias 0.538 0.015 0.020 0.025 0.520 0.002 0.077 −0.013
(MSE) (0.395) (0.059) (0.164) (0.166) (0.784) (0.407) (0.055) (0.149) (0.146) (0.757)
CML Bias 0.544 0.017 −0.002 0.018 0.530 0.699 0.046 −0.013
(MSE) (0.384) (0.030) (0.088) (0.161) (0.663) (0.399) (0.515) (0.073) (0.141) (1.128)
EB Bias 0.543 0.016 0.008 0.018 0.528 0.078 0.059 −0.013
(MSE) (0.385) (0.039) (0.112) (0.161) (0.697) (0.401) (0.066) (0.097) (0.141) (0.705)
†All cases with E = 1 are included in phase II, however, controls are randomly selected for phase II.
∗The combined MSEs over all four parameters.
TPFB uses the informative prior N(0,10−2) on the G-G and G-E associations in the model (2.2). TPFBemp uses the prior N(0, θˆ
2) on
G-G and G-E associations in the model (2.2) where θˆ2 is empirically estimated as the G-G or G-E association parameter under the
controls.
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5. Discussion. We presented a flexible Bayesian approach to estimate
gene–gene (G x G) and/or gene-environment (G x E) interactions under
two-phase sampling with multiple markers. The proposed approach can
handle multiple genetic and environmental factors. The method can trade
off between bias and efficiency by incorporating uncertainty around gene-
environment independence through the hierarchical structure in a data-
adaptive way. The underlying ingredients of this hierarchy are the disease
risk model, the multivariate gene model and the joint model for the environ-
ment factors/covariates, respectively. Our method can also handle potential
missingness in genetic information due to technical inconsistency or due to
merging different studies or cohorts, leading to nonmonotone missing data
structure at the phase II subsample. This paper is the first Bayesian paper
with retrospective modeling for G x E studies under two-phase sampling
that can handle multiple markers.
We compared our method to simpler alternatives such as UML, CML
and EB that use gene-environment independence but only based on phase
II data, ignoring biased sampling. We also considered methods that account
for biased sampling at phase II: weighted likelihood and pseudo-likelihood,
but do not leverage the independence assumption. Our method provides a
framework that integrates both of these features. In a clinical study like the
MECC example, where interest lies in estimating the differential effect of
statin use across genetic subgroups for devising targeted prevention strate-
gies, estimates of main effects as well as gene-environment interaction are
equally important, thus both estimates need to be assessed. In terms of ag-
gregate MSE, our method has superior performance across a wide range of
scenarios over the competing method.
There are some limitations of the current paper that need to be expanded
and explored in future studies. First, we do not fully address the perfor-
mance of our method in the presence of a truly high-dimensional gene model
through simulation studies. The method is scalable to handle up to 294 SNPs
and pairwise interactions in our data example, but we have not carried out
a simulation study due to computation time. We also need to deal with
the exponentially increasing number of G x E and G x G interactions in
the disease risk model as well as G-E/G-G/G-S associations in the multi-
variate gene model, as we add more G-variables in the model. We address
this by Bayesian variable selection and assuming a common parameter for
G-E/G-G/G-S association on genes in the same pathway in the multivari-
ate gene model. The latter is a rather ad-hoc strategy for reducing the
dimension and is a limitation of our method. Bias in parameter estimates
is expected to arise under departures from this assumption. Calculation of
P (D) in the denominator of the likelihood could also pose challenges with
truly high-dimensional data. Second, we have not tested the Bhattacharya
and Dunson (2012) algorithm for the mixed set of discrete and continuous
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covariates in W . Future research will focus on the higher-dimensional G and
E settings, more general structure of the W vector as well as the possibility
of capturing higher order interactions, not just pairwise interactions.
For practitioners who want to choose a design strategy to enhance the
power of screening G x E effects with a relatively rare exposure, exposure
enrichment of cases and controls for collecting genotype data is a better
strategy than random sampling. The tools we developed in the paper pro-
vides a way to account for the biased sampling. The approach also allows
one to explore a multivariate model with multiple SNPs and environmen-
tal exposure and identify potentially informative predictors. If the inter-
est lies in characterizing subgroup effects of E across different subgroups
defined by G, this design and analysis strategy is particularly powerful.
We recommend the use of default prior choices in the codes available at
http://www.umich.edu/~jaeil/tp.zip and recommend using TPFBemp
as the analysis to be reported. For prescribing a preventive medicine pro-
phylactically, like use of statins for colorectal cancer, identifying genetic
subgroups that will receive the most benefit from such a therapy is partic-
ularly helpful. Characterizing G x E effects furthers our understanding of
such subgroup effects for tailoring targeted prevention strategies.
SUPPLEMENTARY MATERIAL
Bayesian semiparametric analysis for two-phase studies of gene-environ-
ment interaction (DOI: 10.1214/12-AOAS599SUPP; .pdf). We consider two-
phase studies of G x E interaction where phase I data is available on expo-
sure, covariates and disease status and stratified sampling is done to prior-
itize individuals for genotyping at phase II. We consider a Bayesian analy-
sis based on the joint retrospective likelihood of phases I and II data that
handles multiple genetic and environmental factors, data adaptive use of
gene-environment independence.
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